Oncolytics Biotech Inc. (ONCY) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Calgary, AB, 加拿大. 现任CEO为 Jared Kelly.
ONCY 拥有 IPO日期为 2001-10-05, 28 名全职员工, 在 NASDAQ Capital Marke, 市值为 $110.4M.
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
